AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimizest MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Alniche Life Sciences Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimizest MV 2mg/500mg/0.2mg Tablet

Glimizest MV 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintaining regular meals and carrying a rapid-acting glucose source (e.g., sugary snacks or juice) is vital. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests (blood cell counts and liver function) will be recommended by your doctor.

Uses of Glimizest MV 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glimizest MV 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimizest MV 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume on an empty stomach.

Common Side effects of Glimizest MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimizest MV 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume the Glimizest MV 2mg/500mg/0.2mg Tablet on an empty stomach.

How Glimizest MV 2mg/500mg/0.2mg Tablet works:

One tablet of Glimizest MV contains 2mg, 500mg, and 0.2mg of three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimizest MV 2mg/500mg/0.2mg tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimizest MV 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Nursing mothers should likely avoid Glimizest MV 2mg/500mg/0.2mg Tablets. Available evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

The use of Glimizest MV 2mg/500mg/0.2mg tablets in individuals with kidney impairment is likely inadvisable and should be forgone. Patients should seek medical counsel. Specifically, this medication is contraindicated for those with severe kidney disease.

LiverLiverCAUTION

Exercise caution when prescribing Glimizest MV 2mg/500mg/0.2mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Consult a physician for guidance. A reduced initial dose is typically advised for patients exhibiting mild to moderate liver disease; the medication is contraindicated in those with severe liver dysfunction.

What if you forget to take Glimizest MV 2mg/500mg/0.2mg Tablet :

Should you forget a Glimizest MV 2mg/500mg/0.2mg Tablet, take it immediately if you remember. Otherwise, omit the missed dose if your next scheduled dose is imminent; resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimizest MV 2mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Glimizest MV 2mg/500mg/0.2mg Tablet

Glimizest MV 2mg/500mg/0.2mg tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults. Effective blood sugar control requires its use alongside a healthy diet and regular physical activity. Glimepiride enhances insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal glucose levels. This medication is unsuitable for treating type 1 diabetes.
Taking Glimizest MV 2mg/500mg/0.2mg tablets may result in common adverse reactions including low blood sugar, queasiness, loose stools, taste disturbances, gas, abdominal discomfort, head pain, skin eruptions, and upper respiratory infections.
Patients with hypersensitivity to any Glimizest MV 2mg/500mg/0.2mg Tablet constituent or inactive ingredient should not take this medication. Furthermore, its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and pre-existing metabolic acidosis, including diabetic ketoacidosis.
Combining Glimizest MV 2mg/500mg/0.2mg tablets and alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and elevates the likelihood of lactic acidosis.
Indeed, Glimizest MV 2mg/500mg/0.2mg Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. These are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other diabetes medications are concurrently used. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any unused medication. Prevent access by children, pets, and others.
Glimizest MV 2mg/500mg/0....
111
MRP 135
17% off